Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06655857 · ClinicalTrials.gov registry record · NA

Interventions for Promoting Kidney Transplant Empowerment

A NA study of Kidney Transplant Waitlisting, sponsored by Icahn School of Medicine at Mount Sinai.

Recruiting
Registry status
NA
Development phase
5
Enrollment target
3
Study locations

NCT06655857 is a NA study of Kidney Transplant Waitlisting that is actively recruiting participants, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 5 participants. The trial reports 3 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06655857, a NA study of Kidney Transplant Waitlisting, is actively recruiting participants, sponsored by Icahn School of Medicine at Mount Sinai.

RECRUITING
Registry status
NA
Development phase
5 participants
Enrollment target
3
Study locations

Study Summary

This is a cluster randomized controlled clinical trial evaluating the effect of community health workers (CHWs) and provider education on kidney transplant (KTx) waitlisting compared to usual care (waitlist control). CKD/HD providers will be randomized to intervention or control, and all patients with the same providers will be in the same randomization group. CHWs will address unmet social needs and patient symptoms through evaluations and linkage to clinical and community services. Intervention providers will receive education, which will include training on working with CHWs, reducing bias in clinical decision-making, and increasing affirming/reducing stigmatizing language in electronic health records (EHRs).

Interventions

  • OTHER Usual Care
  • OTHER Community Health Worker Assistance
  • OTHER Intervention Providers

Study Locations (3)

New York

  • NYU Langone Health - New York
  • Mount Sinai Hospital - New York
  • Montefiore Einstein - The Bronx

Trial Details

FieldValue
Enrollment Target 5 participants
Start Date 2025-08-05
Est. Completion 2026-03-31
Phase NA

What the Registry Record Tells You About NCT06655857

The ClinicalTrials.gov registry entry for NCT06655857 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Icahn School of Medicine at Mount Sinai, which has 708 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Kidney Transplant Waitlisting appearing as the primary indexed condition, and to 3 interventions - of which Usual Care is the first listed.

NCT06655857 reports 3 study locations spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT06655857 about?

NCT06655857 is a clinical study titled "Interventions for Promoting Kidney Transplant Empowerment". This is a cluster randomized controlled clinical trial evaluating the effect of community health workers (CHWs) and provider education on kidney transplant (KTx) waitlisting compared to usual care (waitlist control). CKD/HD providers will be randomized to intervention or control, and all patients wi...

What is the current status of trial NCT06655857?

This trial is currently recruiting. It is a NA study. The enrollment target is 5 participants. The study started on 2025-08-05. Estimated completion is 2026-03-31.

What conditions does trial NCT06655857 study?

This clinical trial studies the following conditions: Kidney Transplant Waitlisting.

What interventions are being tested in trial NCT06655857?

The interventions under investigation include: Usual Care (OTHER), Community Health Worker Assistance (OTHER), Intervention Providers (OTHER).

Who is sponsoring clinical trial NCT06655857?

This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06655857 being conducted?

This trial has 3 study locations across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.